Oncotarget
The cover for issue 8 of Oncotarget features Figure 11, "The viability of TS543 human glioma spheroid cultures following treatments with CBD, ATM inhibitor (ATMi), and γ-irradiation (5 Gy), alone or in combination," by Ivanov, et al.
Know your limits: RPA availability and chemoresistance in ovarian cancer |
https://doi.org/10.18632/oncotarget.26607 Emile Fortier, Elliot Drobetsky, and Hugo Wurtele |
800-802 |
PDF | How to cite | Order a Reprint |
Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancer |
https://doi.org/10.18632/oncotarget.26611 Matteo Lambertini, and Giulia Viglietti |
803-804 |
PDF | How to cite | Order a Reprint |
Antiphospholipid immune complexes as thrombosis risk marker |
https://doi.org/10.18632/oncotarget.26612 José A. Martínez-Flores, Manuel Serrano, and Antonio Serrano |
805-806 |
PDF | How to cite | Order a Reprint |
Physical activity fragmentation as a potential phenotype of accelerated aging |
https://doi.org/10.18632/oncotarget.26631 Amal A. Wanigatunga, Luigi Ferrucci, and Jennifer A. Schrack |
807-809 |
PDF | How to cite | Order a Reprint |
Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer |
https://doi.org/10.18632/oncotarget.26574 Edna Gordian, Eric A. Welsh, Nicholas Gimbrone, Erin M. Siegel, David Shibata, Ben C. Creelan, William Douglas Cress, Steven A. Eschrich, Eric B. Haura, and Teresita Muñoz-Antonia |
810-824 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Inhibition of ATM kinase upregulates levels of cell death induced by cannabidiol and γ-irradiation in human glioblastoma cells |
https://doi.org/10.18632/oncotarget.26582 Vladimir N. Ivanov, Jinhua Wu, Tony J.C. Wang, and Tom K. Hei |
825-846 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Triplet chemotherapy with docetaxel, cisplatin and S-1 for unresectable advanced squamous cell carcinoma of the esophagus: phase I/II trial results |
https://doi.org/10.18632/oncotarget.26614 Toshiyasu Ojima, Masaki Nakamura, Mikihito Nakamori, Masahiro Katsuda, Keiji Hayata, Junya Kitadani, Shimpei Maruoka, Toshio Shimokawa, and Hiroki Yamaue |
847-855 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles |
https://doi.org/10.18632/oncotarget.26615 Harold W. Davis, Subrahmanya D. Vallabhapurapu, Zhengtao Chu, Swarajya L. Vallabhapurapu, Robert S. Franco, Michelle Mierzwa, William Kassing, William L. Barrett, and Xiaoyang Qi |
856-868 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia |
https://doi.org/10.18632/oncotarget.26617 Fabio Forghieri, Giovanni Riva, Ivana Lagreca, Patrizia Barozzi, Daniela Vallerini, Monica Morselli, Ambra Paolini, Paola Bresciani, Elisabetta Colaci, Monica Maccaferri, Andrea Gilioli, Vincenzo Nasillo, Andrea Messerotti, Valeria Pioli, Laura Arletti, Davide Giusti, Francesca Bettelli, Melania Celli, Francesca Donatelli, Giorgia Corradini, Sabrina Basso, Antonella Gurrado, Monica Cellini, Tommaso Trenti, Roberto Marasca, Franco Narni, Maria Paola Martelli, Brunangelo Falini, Leonardo Potenza, Mario Luppi, and Patrizia Comoli |
869-882 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Oxygen in the tumor microenvironment: effects on dendritic cell function |
https://doi.org/10.18632/oncotarget.26608 Laurent M. Paardekooper, Willemijn Vos, and Geert van den Bogaart |
883-896 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells |
https://doi.org/10.18632/oncotarget.26618 Neelakshi Mungra, Sandra Jordaan, Precious Hlongwane, Krupa Naran, Shivan Chetty, and Stefan Barth |
897-915 |
Abstract | PDF | Full Text | How to cite | Order a Reprint |
Correction: γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers |
https://doi.org/10.18632/oncotarget.26649 Nuša Trošt, Samuel Peña-Llopis, Sajjan Koirala, Jurij Stojan, Patrick Ryan Potts, Klementina Fon Tacer, and Elisabeth D. Martinez |
916-916 |
Correction | PDF | How to cite |
Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer |
https://doi.org/10.18632/oncotarget.26650 Barbara Adamo, Giuseppina Rosaria Rita Ricciardi, Antonio Ieni, Tindara Franchina, Carmine Fazzari, Maria Vita Sanò, Giuseppe Angelico, Michele Caruso, Giovanni Tuccari, and Vincenzo Adamo |
917-917 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC